Li Y, Zhang X, Wang Z, Li B, Zhu H
Prognostic value of a combination of circulating biomarkers in critically ill patients with traumatic brain injury: results from the european CREACTIVE study
Sung YK, Kim SW
Vishnoi K, Viswakarma N, Rana A, Rana B
Cells were subsequently blocked by 2% BSA in PBS-T (0.1% Tween 20 in PBS) for 1 h at room temperature, incubated with the primary antibody Anti-Rheb (Santa Cruz Biotechnology Cat# sc-271509, RRID: AB_10659102, 1:500) overnight at 4 C in blocking buffer, then washed with PBS-T three times and incubated with Alexa-555-conjugated secondary antibody (Invitrogen # A-31570, RRID:AB_2536180, 1: 1000) and DAPI (1 g/ml) in blocking buffer for 1 h at room temperature with protection from light